Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using (89)Zr-DFO-MSTP2109A Anti-STEAP1 Antibody

Six-transmembrane epithelial antigen of prostate-1 (STEAP1) is a relatively newly identified target in prostate cancer. We evaluated the ability of PET/CT with (89)Zr-DFO-MSTP2109A, an antibody that recognizes STEAP1, to detect lesions in patients with metastatic castration-resistant prostate cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Carrasquillo, Jorge A., Fine, Bernard M., Pandit-Taskar, Neeta, Larson, Steven M., Fleming, Stephen E., Fox, Josef J., Cheal, Sarah M., O’Donoghue, Joseph A., Ruan, Shutian, Ragupathi, Govind, Lyashchenko, Serge K., Humm, John L., Scher, Howard I., Gönen, Mithat, Williams, Simon P., Danila, Daniel C., Morris, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836860/
https://ncbi.nlm.nih.gov/pubmed/31053681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.222844
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados